Melbourne, Australia — MPH Nexora Pty Ltd today announced the onboarding of its first institutional testing users onto the MPH Nexora platform, including the Florey Institute of Neuroscience and Mental Health — one of Australia's most respected biomedical research institutions — alongside a number of leading life sciences companies.
The onboarding marks the commencement of structured platform testing with real institutional users, providing MPH Nexora with critical validation data across its core modules including research synthesis, regulatory navigation, and data analytics.
"Having institutions of the calibre of the Florey test our platform is an enormous indication of the power of the platform we are building," said Nigel Blair, Founder and CEO of MPH Nexora. "Their feedback will be instrumental in shaping the final platform ahead of our global launch."
